Keywords
HIV
coinfection
multiple organ failure
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To report a case of SARS-CoV-2/HIV coinfection in a patient with a history of recent lung infections who had a cardiopulmonary arrest on the day of hospitalization for COVID-19 treatment, dying some days after multiple organ failure. Case detail: A 33-year-old immunosuppressed male patient (abandoning treatment for HIV) was admitted to the emergency department with respiratory symptoms and tested positive for SARS-CoV-2. During hospitalization, the patient had a cardiorespiratory arrest and presented a robust inflammatory profile, fungal infection, sepsis, metabolic acidosis, arterial hypertension, thrombosis, hemorrhage, and hepatic, muscular, and renal injury. Finally, he evolved with multiple organ failures, leading to death. Conclusion: Severe immunosuppression caused by HIV, associated with underlying cardiopulmonary diseases, contributes to lethal outcomes of COVID-19.
References
ALSHARIF N, et al. Two pandemics intertwined around one patient: Interstitial pneumonia as the first presentation of HIV/AIDS, be it Pneumocystis jirovecii, cytomegalovirus, SARS-CoV2 or all? A case report. Heliyon, 2023; 9(9): e19615.
BASSO RP, et al. COVID-19-Associated Histoplasmosis in an AIDS Patient. Mycopathologia, 2021; 186(1): 109-112.
BANSAL N, et al. SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward. Transfusion Clinique et Biologique, 2022; 29(2): 161.
BERTOLINI M, et al. COVID-19 associated with AIDS-related disseminated histoplasmosis: a case report. Int J STD AIDS, 2020; 31(12): 1222-1224.
BO XU, et al. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. Journal of Infection, 2020; 81(1): e51-60.
BUDHIRAJA R, et al. Endothelial dysfunction in pulmonary hypertension. Circulat, 2004; 109(2): 159-65.
CDC. Centers for Disease Control and Prevention. COVID-19 and HIV. 2023. Disponível em: https://www.cdc.gov/hiv/basics/covid-19.html. Acessed in: 25 november 2023.
DANDACHI D, et al. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019. Clinical Infectious Diseases, 2021; 73(7): e1964-72.
DAODU J, et al. A rare case of AIDS co-infected with COVID-19 presenting with disseminated Herpes zoster complicated with CMV and Varicella zoster virus meningoencephalitis. Acta Biomed., 2022; 93(6): e2022326.
DÍEZ C, et al. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study. HIV Med., 2021; 22(9): 867-876.
DE FIGUEIREDO IR, et al. Pneumocystosis pneumonia: a comparison study between HIV and non-HIV immunocompromised patients. Pulmonology, 2019; 25(5): 271-4.
EJAMO JY, et al. COVID-19 vaccine acceptance among people living with HIV: A systematic review and meta-analysis. Trop Med Int Health, 2023; 28(8): 601-611.
HELMS J, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive care medicine, 2020; 46(6): 1089-98.
KADIRVELU B, et al. Variation in global COVID-19 symptoms by geography and by chronic disease: A global survey using the COVID-19 Symptom Mapper. EClinicalMedicine, 2022; 45: 101317.
KANWUGU ON e ADADI P. HIV/SARS‐CoV‐2 coinfection: a global perspective. Journal of medical virology, 2021; 93(2): 726-32.
KARMEN-TUOHY S, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. Journal of acquired immune deficiency syndromes, 1999.
HARIYANTO TI e ROSALIND J. Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis, 2021; 22: 1220.
HAPID MH and DEWI TS. COVID-19 Infection as an Exacerbated Factor of Oral Candidiasis in HIV/AIDS Patient. Int Med Case Rep J., 2023; 16: 303-310.
HOFFMANN M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 2020; 181(2): 271-80.
LEITE RO, et al. ATPergic signaling disruption in human sepsis as a potential source of biomarkers for clinical use. Clin Exp Med., 2023; 10.1007/s10238-023-01045-w.
MAARTENS G e BOULLE A. CD4 T-cell responses to combination antiretroviral therapy. The Lancet, 2007; 370(9585): 366-8.
MELLOR MM, et al. Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. AIDS, 2021; 35: F1-f10.
MIR T, et al. Coronavirus disease 2019 (COVID-19): Multisystem review of pathophysiology. Annals of Medicine and Surgery, 2021; 69: 102745.
NAVEED M, et al. Review of potential risk groups for coronavirus disease 2019 (COVID-19). New Microbes and New Infections, 2021; 41: 100849.
PIPITÒ L, et al. Hemophagocytic lymphohistiocytosis secondary to histoplasmosis: A case report in a patient with AIDS and recent SARS-CoV-2 infection and minireview. Heliyon, 2023; 9(8): e18537.
PHILIP T, et al. Spontaneous pneumothorax and COVID-19: Precipitants to a complex HIV-AIDS diagnosis. Radiol Case Rep., 2023; 18(3): 1197-1200.
PENG X, et al. Sharing CD4+ T cell loss: when COVID-19 and HIV collide on immune system. Frontiers in immunology, 2020; 11: 3307.
PLUMMER MM and PAVIA CS. COVID-19 Vaccines for HIV-Infected Patients. Viruses, 2021; 13(10): 1890.
RAVETTI CG, et al. Estudo de pacientes reanimados pós-parada cardiorrespiratória intra e extra-hospitalar submetidos à hipotermia terapêutica. Revista Brasileira de Terapia Intensiva, 2009; 21: 369-375.
TIEMTORE-KAMBOU BM, et al. Aspects scanographiques de la pneumopathie ā COVID-19 ā Ouagadougou: Étude multicentrique ā propos de 1017 cas. Journal of Medical Imaging and Radiation Sciences, 2022; 53(4): 704-13.
YANG J, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis., 2020; 94: 91-95.
WORLD HEALTH ORGANIZATION. 2023 World Health Organization Coronavirus (COVID-19) Dashboard. Disponível em: https://covid19.who.int/. Access in: 3 september 2023.
WORLD HEALTH ORGANIZATION. Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection, 15 July 2021. World Health Organization; 2021.